Next Article in Journal
Current Diagnostic Approach and Screening Methods for Hereditary Spherocytosis
Previous Article in Journal
Expert Services for Rare Anaemias across Europe
 
 
Thalassemia Reports is published by MDPI from Volume 12 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Laboratory Diagnosis of the Rare Anaemias: External Quality Assessment Benefits Patient Care

by
Barbara De La Salle
1,*,
Andrea Mosca
2,
Renata Paleari
2,
Vasileios Rapanakis
1 and
Keith Hyde
1
1
UK NEQAS for General Haematology, Watford, UK
2
University of Milan, Milan, Italy
*
Author to whom correspondence should be addressed.
Thalass. Rep. 2013, 3(s1), e31; https://doi.org/10.4081/thal.2013.s1.e31
Submission received: 24 February 2013 / Revised: 17 March 2013 / Accepted: 19 March 2013 / Published: 26 March 2013

Abstract

Since its introduction in the 1960s, external quality assessment has developed to become an essential component of the quality management system of the diagnostic laboratory. External quality assessment provides a long term, retrospective view of laboratory performance, demonstrating the competence of the laboratory to others. The ENERCA project (the European Network for Rare and Congenital Anaemias) has established a list of core laboratory tests that are used in the diagnosis of rare and congenital anaemias, which has been used as the basis for questionnaires to laboratories, to establish the use and quality assurance of diagnostic testing in the congenital and rare anaemias, and to European EQA providers for services in this key area. In general, the provision of EQA for rare and congenital anaemias is widely variable with little provision for the very rare disorders. For the more common congenital anaemias, such as the haemoglobinopathies and thalassaemias, provision is better but there is variation in aspects of the scheme design, especially the frequency of distribution. Where laboratories did not take part in EQA for individual tests, or there was no EQA available, a desire to participate was expressed in 66% (102/154) of cases. The provision of external quality assessment (EQA) services for rare disorders is a challenge. For many of these conditions, the number of patients in any one member state is very small with only a few laboratories providing diagnostic testing. In these cases, the development of pan-European or cross-border EQA may be the only means by which standardisation of methods and results can be achieved. An EQA survey of 243 laboratories for performance in Hb A2 quantification showed encouraging results in that there was a clear differentiation in the results from a beta Thalassaemia carrier and an individual with no evidence of Thalassaemia; however, a bias was observed between different methods of measurement.

Share and Cite

MDPI and ACS Style

De La Salle, B.; Mosca, A.; Paleari, R.; Rapanakis, V.; Hyde, K. Laboratory Diagnosis of the Rare Anaemias: External Quality Assessment Benefits Patient Care. Thalass. Rep. 2013, 3, e31. https://doi.org/10.4081/thal.2013.s1.e31

AMA Style

De La Salle B, Mosca A, Paleari R, Rapanakis V, Hyde K. Laboratory Diagnosis of the Rare Anaemias: External Quality Assessment Benefits Patient Care. Thalassemia Reports. 2013; 3(s1):e31. https://doi.org/10.4081/thal.2013.s1.e31

Chicago/Turabian Style

De La Salle, Barbara, Andrea Mosca, Renata Paleari, Vasileios Rapanakis, and Keith Hyde. 2013. "Laboratory Diagnosis of the Rare Anaemias: External Quality Assessment Benefits Patient Care" Thalassemia Reports 3, no. s1: e31. https://doi.org/10.4081/thal.2013.s1.e31

Article Metrics

Back to TopTop